ITGAX and neoplasm: Tumor-inoculated mice treated with i.v. licofelone-vaccine plus additional s.c. licofelone showed a decrease in the frequency of Gr-1− F4/80+ macrophages and CD11c+ cells in spleen and, for Gr-1− F4/80+ macrophages, in BM (Figure 2).